Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina K Edgerly

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Human Molecular Genetics|July 28, 2010
Mitochondrial loss, dysfunction and altered dynamics in Huntington's diseaseJinho Kim, Jennifer P Moody, Christina K Edgerly, et al.
ACS Medicinal Chemistry Letters|July 28, 2012
Chiral cyclohexane 1,3-diones as inhibitors of mutant SOD1-dependent protein aggregation for the treatment of ALSYinan Zhang, Radhia Benmohamed, Wei Zhang, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
Correction to "Chiral Cyclohexane 1,3-Diones as Inhibitors of Mutant SOD1-Dependent Protein Aggregation for the Treatment of ALS"Yinan Zhang, Radhia Benmohamed, Wei Zhang, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|June 23, 2010
Uridine ameliorates the pathological phenotype in transgenic G93A-ALS miceDaniel J Amante, Jinho Kim, Samantha T Carreiro, et al.
Biochimica Et Biophysica Acta|May 13, 2010
Reduced creatine kinase as a central and peripheral biomarker in Huntington's diseaseJinho Kim, Daniel J Amante, Jennifer P Moody, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Defining the role of syndecan-4 in mechanotransduction using surface-modification approachesRobert M Bellin, James D Kubicek, Matthew J Frigault, et al.
Plos Biology|June 25, 2014
The Wnt receptor Ryk reduces neuronal and cell survival capacity by repressing FOXO activity during the early phases of mutant huntingtin pathogenicityCendrine Tourette, Francesca Farina, Rafael P Vazquez-Manrique, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Human Molecular Genetics|July 28, 2010
Mitochondrial loss, dysfunction and altered dynamics in Huntington's diseaseJinho Kim, Jennifer P Moody, Christina K Edgerly, et al.
ACS Medicinal Chemistry Letters|July 28, 2012
Chiral cyclohexane 1,3-diones as inhibitors of mutant SOD1-dependent protein aggregation for the treatment of ALSYinan Zhang, Radhia Benmohamed, Wei Zhang, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
Correction to "Chiral Cyclohexane 1,3-Diones as Inhibitors of Mutant SOD1-Dependent Protein Aggregation for the Treatment of ALS"Yinan Zhang, Radhia Benmohamed, Wei Zhang, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|June 23, 2010
Uridine ameliorates the pathological phenotype in transgenic G93A-ALS miceDaniel J Amante, Jinho Kim, Samantha T Carreiro, et al.
Biochimica Et Biophysica Acta|May 13, 2010
Reduced creatine kinase as a central and peripheral biomarker in Huntington's diseaseJinho Kim, Daniel J Amante, Jennifer P Moody, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Defining the role of syndecan-4 in mechanotransduction using surface-modification approachesRobert M Bellin, James D Kubicek, Matthew J Frigault, et al.
Plos Biology|June 25, 2014
The Wnt receptor Ryk reduces neuronal and cell survival capacity by repressing FOXO activity during the early phases of mutant huntingtin pathogenicityCendrine Tourette, Francesca Farina, Rafael P Vazquez-Manrique, et al.
Pageof 1